Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
Clinical trial NCT00522145 · COMPLETED
Trial details
- NCT number
- NCT00522145
- Sponsor
- Kadmon Corporation, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2009-10-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.